NAPP TECHNOLOGIES INC

Overview

NAPP TECHNOLOGIES INC is an active pharmaceutical ingredient (API) supplier with 6 active FDA Type II Drug Master Files, covering 4-AMINOPYRIDINE; ACETAZOLAMIDE, USP; CELL CULTURE MEDIA; INCHINNAN AGT MEDIA; MYCOSEQ MYCOPLASMA DETECTION SYSTEM; SULFANILAMIDE.

API / Drug Master Files

NAPP TECHNOLOGIES INC holds 6 active (21 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• INCHINNAN AGT MEDIAActive2016-08-02
• MYCOSEQ MYCOPLASMA DETECTION SYSTEMActive2010-04-30
• ACETAZOLAMIDE, USPActive2009-01-22
• CELL CULTURE MEDIAActive2004-12-15
• SULFANILAMIDEActive1985-08-20
• 4-AMINOPYRIDINEActive1983-03-03
• HUMAN GROWTH FACTORSInactive2011-07-11
• DAPSONE, USPInactive2011-06-29
• POROS CHROMATOGRAPHIC RESINSInactive2001-10-18
• KETOCONAZOLE USPInactive2000-06-30
• SULFABENZAMIDEInactive1999-12-29
• NABUMETONEInactive1997-03-18
• WARFARIN SODIUM CLATHRATEInactive1996-08-27
• KERATINOCYTE-SFM (SERUM FREE KERATINOCYTE MEDIUM) PRODUCED IN GRAND ISLAND, NEW YORK.Inactive1993-03-31
• SF-900 II SFM (OPTIMIZED SERUM-FREE MEDIUM FOR INSECT CELL CULTURE, COMPLETE)Inactive1992-10-23

Showing 15 of 21 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to NAPP TECHNOLOGIES INC in our records. PharmaTek screens the full directory against live FDA enforcement data.